Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children

Shwetal Lalan, Shuai Jiang, Derek Ng, Fernanda Kupferman, Bradley A. Warady, Susan Furth, Mark M. Mitsnefes

Research output: Contribution to journalArticle

Abstract

Objective: To estimate the prevalence of metabolic syndrome (MetS) and examine its association with chronic kidney disease progression in children enrolled in the Chronic Kidney Disease in Children study. Study design: MetS was defined as being overweight or obese and having ≥2 cardiometabolic risk factors (CMRFs). Incidence and prevalence of MetS were assessed using pairs of visits approximately 2 years apart. Results: A total of 799 pairs of person-visits (contributed by 472 children) were included in the final analysis. Of these, 70% had a normal body mass index (BMI), 14% were overweight, and 16% were obese. At the first visit, the prevalence of MetS in the overweight group was 40% and in the obese group was 60%. In adjusted models, annual percent estimated glomerular filtration rate decline in those who had normal BMI and incident or persistent multiple CMRFs or those with persistent MetS was −6.33%, −6.46%, and −6.08% (respectively) compared with children who never had multiple CMRFs (−3.38%, P = .048, .045, and .036, respectively). Children with normal BMI and incident multiple CMRFs and those with persistent MetS had approximately twice the odds of fast estimated glomerular filtration rate decline (>10% per year) compared with those without multiple CMRFs and normal BMI. Conclusion: Children with chronic kidney disease have a high prevalence of MetS. These children as well as those with normal BMI but multiple CMRFs experience a faster decline in kidney function.

Original languageEnglish (US)
JournalJournal of Pediatrics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Chronic Renal Insufficiency
Disease Progression
Body Mass Index
Glomerular Filtration Rate
Kidney
Incidence

Keywords

  • cardiovascular risk
  • children
  • chronic kidney disease
  • metabolic syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children. / Lalan, Shwetal; Jiang, Shuai; Ng, Derek; Kupferman, Fernanda; Warady, Bradley A.; Furth, Susan; Mitsnefes, Mark M.

In: Journal of Pediatrics, 01.01.2018.

Research output: Contribution to journalArticle

Lalan, Shwetal ; Jiang, Shuai ; Ng, Derek ; Kupferman, Fernanda ; Warady, Bradley A. ; Furth, Susan ; Mitsnefes, Mark M. / Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children. In: Journal of Pediatrics. 2018.
@article{8524a2a1cbba4827a571a3700a5b5e0e,
title = "Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children",
abstract = "Objective: To estimate the prevalence of metabolic syndrome (MetS) and examine its association with chronic kidney disease progression in children enrolled in the Chronic Kidney Disease in Children study. Study design: MetS was defined as being overweight or obese and having ≥2 cardiometabolic risk factors (CMRFs). Incidence and prevalence of MetS were assessed using pairs of visits approximately 2 years apart. Results: A total of 799 pairs of person-visits (contributed by 472 children) were included in the final analysis. Of these, 70{\%} had a normal body mass index (BMI), 14{\%} were overweight, and 16{\%} were obese. At the first visit, the prevalence of MetS in the overweight group was 40{\%} and in the obese group was 60{\%}. In adjusted models, annual percent estimated glomerular filtration rate decline in those who had normal BMI and incident or persistent multiple CMRFs or those with persistent MetS was −6.33{\%}, −6.46{\%}, and −6.08{\%} (respectively) compared with children who never had multiple CMRFs (−3.38{\%}, P = .048, .045, and .036, respectively). Children with normal BMI and incident multiple CMRFs and those with persistent MetS had approximately twice the odds of fast estimated glomerular filtration rate decline (>10{\%} per year) compared with those without multiple CMRFs and normal BMI. Conclusion: Children with chronic kidney disease have a high prevalence of MetS. These children as well as those with normal BMI but multiple CMRFs experience a faster decline in kidney function.",
keywords = "cardiovascular risk, children, chronic kidney disease, metabolic syndrome",
author = "Shwetal Lalan and Shuai Jiang and Derek Ng and Fernanda Kupferman and Warady, {Bradley A.} and Susan Furth and Mitsnefes, {Mark M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jpeds.2018.06.007",
language = "English (US)",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children

AU - Lalan, Shwetal

AU - Jiang, Shuai

AU - Ng, Derek

AU - Kupferman, Fernanda

AU - Warady, Bradley A.

AU - Furth, Susan

AU - Mitsnefes, Mark M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: To estimate the prevalence of metabolic syndrome (MetS) and examine its association with chronic kidney disease progression in children enrolled in the Chronic Kidney Disease in Children study. Study design: MetS was defined as being overweight or obese and having ≥2 cardiometabolic risk factors (CMRFs). Incidence and prevalence of MetS were assessed using pairs of visits approximately 2 years apart. Results: A total of 799 pairs of person-visits (contributed by 472 children) were included in the final analysis. Of these, 70% had a normal body mass index (BMI), 14% were overweight, and 16% were obese. At the first visit, the prevalence of MetS in the overweight group was 40% and in the obese group was 60%. In adjusted models, annual percent estimated glomerular filtration rate decline in those who had normal BMI and incident or persistent multiple CMRFs or those with persistent MetS was −6.33%, −6.46%, and −6.08% (respectively) compared with children who never had multiple CMRFs (−3.38%, P = .048, .045, and .036, respectively). Children with normal BMI and incident multiple CMRFs and those with persistent MetS had approximately twice the odds of fast estimated glomerular filtration rate decline (>10% per year) compared with those without multiple CMRFs and normal BMI. Conclusion: Children with chronic kidney disease have a high prevalence of MetS. These children as well as those with normal BMI but multiple CMRFs experience a faster decline in kidney function.

AB - Objective: To estimate the prevalence of metabolic syndrome (MetS) and examine its association with chronic kidney disease progression in children enrolled in the Chronic Kidney Disease in Children study. Study design: MetS was defined as being overweight or obese and having ≥2 cardiometabolic risk factors (CMRFs). Incidence and prevalence of MetS were assessed using pairs of visits approximately 2 years apart. Results: A total of 799 pairs of person-visits (contributed by 472 children) were included in the final analysis. Of these, 70% had a normal body mass index (BMI), 14% were overweight, and 16% were obese. At the first visit, the prevalence of MetS in the overweight group was 40% and in the obese group was 60%. In adjusted models, annual percent estimated glomerular filtration rate decline in those who had normal BMI and incident or persistent multiple CMRFs or those with persistent MetS was −6.33%, −6.46%, and −6.08% (respectively) compared with children who never had multiple CMRFs (−3.38%, P = .048, .045, and .036, respectively). Children with normal BMI and incident multiple CMRFs and those with persistent MetS had approximately twice the odds of fast estimated glomerular filtration rate decline (>10% per year) compared with those without multiple CMRFs and normal BMI. Conclusion: Children with chronic kidney disease have a high prevalence of MetS. These children as well as those with normal BMI but multiple CMRFs experience a faster decline in kidney function.

KW - cardiovascular risk

KW - children

KW - chronic kidney disease

KW - metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=85049338560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049338560&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2018.06.007

DO - 10.1016/j.jpeds.2018.06.007

M3 - Article

C2 - 30041938

AN - SCOPUS:85049338560

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

ER -